The LIM Protein Ajuba Influences Interleukin-1-induced NF-kappaB Activation by Affecting the Assembly and Activity of the Protein Kinase Czeta/p62/TRAF6 Signaling Complex

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2005 May 5

PMID 15870274

Citations 44

Authors

Yungfeng Feng

Gregory D Longmore

Affiliations

Soon will be listed here.

Abstract

The Zyxin/Ajuba family of cytosolic LIM domain-containing proteins has the potential to shuttle from sites of cell adhesion into the nucleus and thus can be candidate transducers of environmental signals. To understand Ajuba's role in signal transduction pathways, we performed a yeast two-hybrid screen with the LIM domain region of Ajuba. We identified the atypical protein kinase C (aPKC) scaffold protein p62 as an Ajuba binding partner. A prominent function of p62 is the regulation of NF-kappaB activation in response to interleukin-1 (IL-1) and tumor necrosis factor signaling through the formation of an aPKC/p62/TRAF6 multiprotein signaling complex. In addition to p62, we found that Ajuba also interacted with tumor necrosis factor receptor-associated factor 6 (TRAF6) and PKCzeta. Ajuba recruits TRAF6 to p62 and in vitro activates PKCzeta activity and is a substrate of PKCzeta. Ajuba null mouse embryonic fibroblasts (MEFs) and lungs were defective in NF-kappaB activation following IL-1 stimulation, and in lung IKK activity was inhibited. Overexpression of Ajuba in primary MEFs enhances NF-kappaB activity following IL-1 stimulation. We propose that Ajuba is a new cytosolic component of the IL-1 signaling pathway modulating IL-1-induced NF-kappaB activation by influencing the assembly and activity of the aPKC/p62/TRAF6 multiprotein signaling complex.

Citing Articles

p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair.

Yang X, Cao X, Zhu Q Cancer Metastasis Rev. 2025; 44(1):33.

PMID: 39954143 PMC: 11829845. DOI: 10.1007/s10555-025-10250-w.

The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function.

Sultana M, Cluning C, Kwong W, Polain N, Pavlos N, Ratajczak T PLoS One. 2021; 16(11):e0259556.

PMID: 34735553 PMC: 8568271. DOI: 10.1371/journal.pone.0259556.

A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.

Swaney D, Ramms D, Wang Z, Park J, Goto Y, Soucheray M Science. 2021; 374(6563):eabf2911.

PMID: 34591642 PMC: 9005332. DOI: 10.1126/science.abf2911.

The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway.

Wang L, Howell M, Sparks-Wallace A, Zhao J, Hensley C, Nicksic C mBio. 2021; 12(5):e0109721.

PMID: 34488443 PMC: 8546576. DOI: 10.1128/mBio.01097-21.

Exploring the dermotoxicity of the mycotoxin deoxynivalenol: combined morphologic and proteomic profiling of human epidermal cells reveals alteration of lipid biosynthesis machinery and membrane structural integrity relevant for skin barrier function.

Del Favero G, Janker L, Neuditschko B, Hohenbichler J, Kiss E, Woelflingseder L Arch Toxicol. 2021; 95(6):2201-2221.

PMID: 33890134 PMC: 8166681. DOI: 10.1007/s00204-021-03042-y.

References

Kiss H, Kedra D, Yang Y, Kost-Alimova M, Kiss C, OBrien K . A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3. Hum Genet. 2000; 105(6):552-9. DOI: 10.1007/s004399900188. View

Arch R, Gedrich R, Thompson C . Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. Genes Dev. 1998; 12(18):2821-30. DOI: 10.1101/gad.12.18.2821. View

Sanz L, Diaz-Meco M, Nakano H, Moscat J . The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J. 2000; 19(7):1576-86. PMC: 310227. DOI: 10.1093/emboj/19.7.1576. View

Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T . Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol. 2000; 149(5):1073-86. PMC: 2174824. DOI: 10.1083/jcb.149.5.1073. View

Kanungo J, Pratt S, Marie H, Longmore G . Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions. Mol Biol Cell. 2000; 11(10):3299-313. PMC: 14993. DOI: 10.1091/mbc.11.10.3299. View

Deng L, Wang C, Spencer E, Yang L, Braun A, You J . Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000; 103(2):351-61. DOI: 10.1016/s0092-8674(00)00126-4. View

Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S . Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 2001; 20(6):1271-80. PMC: 145527. DOI: 10.1093/emboj/20.6.1271. View

Wooten M, Seibenhener M, Mamidipudi V, Diaz-Meco M, Barker P, Moscat J . The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. J Biol Chem. 2001; 276(11):7709-12. DOI: 10.1074/jbc.C000869200. View

Leitges M, Sanz L, MARTIN P, Duran A, Braun U, Garcia J . Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell. 2001; 8(4):771-80. DOI: 10.1016/s1097-2765(01)00361-6. View

10.

Renfranz P, Beckerle M . Doing (F/L)PPPPs: EVH1 domains and their proline-rich partners in cell polarity and migration. Curr Opin Cell Biol. 2002; 14(1):88-103. DOI: 10.1016/s0955-0674(01)00299-x. View

11.

Geetha T, Wooten M . Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett. 2002; 512(1-3):19-24. DOI: 10.1016/s0014-5793(02)02286-x. View

12.

Marie H, Billups D, Bedford F, Dumoulin A, Goyal R, Longmore G . The amino terminus of the glial glutamate transporter GLT-1 interacts with the LIM protein Ajuba. Mol Cell Neurosci. 2002; 19(2):152-64. DOI: 10.1006/mcne.2001.1066. View

13.

Ostendorff H, Peirano R, Peters M, Schluter A, Bossenz M, Scheffner M . Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors. Nature. 2002; 416(6876):99-103. DOI: 10.1038/416099a. View

14.

Kashatus D, Chen S, Li X, Westwick J, Davis R, Earp H . The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol. 2002; 22(23):8175-83. PMC: 134075. DOI: 10.1128/MCB.22.23.8175-8183.2002. View

15.

Marie H, Pratt S, Betson M, Epple H, Kittler J, Meek L . The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin. J Biol Chem. 2002; 278(2):1220-8. DOI: 10.1074/jbc.M205391200. View

16.

Dunne A, ONeill L . The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE. 2003; 2003(171):re3. DOI: 10.1126/stke.2003.171.re3. View

17.

Garvalov B, Higgins T, Sutherland J, Zettl M, Scaplehorn N, Kocher T . The conformational state of Tes regulates its zyxin-dependent recruitment to focal adhesions. J Cell Biol. 2003; 161(1):33-9. PMC: 2172870. DOI: 10.1083/jcb.200211015. View

18.

Hirai T, Chida K . Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J Biochem. 2003; 133(1):1-7. DOI: 10.1093/jb/mvg017. View

19.

Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L . SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol. 2003; 4(9):920-7. DOI: 10.1038/ni968. View

20.

Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M . Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell. 2003; 114(5):585-98. DOI: 10.1016/s0092-8674(03)00642-1. View